ENPICOM OPENS SATELLITE OFFICE ON SCIENCE PARK AMSTERDAM
ENPICOM OPENS SATELLITE OFFICE ON SCIENCE PARK AMSTERDAM On August 1, ENPICOM opened a new satellite [...]
ENPICOM HAS BEEN RECOGNIZED AS ONE OF THE 15 MOST PROMISING BIOTECH STARTUPS OF EUROPE IN 2019
ENPICOM HAS BEEN RECOGNIZED AS ONE OF THE 15 MOST PROMISING BIOTECH STARTUPS OF EUROPE [...]
INTRODUCING THE IGX PLATFORM TO THE AIRR COMMUNITY
INTRODUCING THE IGX PLATFORM TO THE AIRR COMMUNITY From the 10th to the 15th of May, ENPICOM [...]
DDL Diagnostic Laboratory and ENPICOM Join Forces to Deliver Unique Immune Repertoire Sequencing and Data Analysis Service
DDL DIAGNOSTIC LABORATORY AND ENPICOM JOIN FORCES TO DELIVER UNIQUE IMMUNE [...]
ENPICOM Launches Unique Immune Sequencing Data Analysis Platform
ENPICOM LAUNCHES UNIQUE IMMUNE SEQUENCING DATA ANALYSIS PLATFORM Bridging the gap between repertoire sequencing and [...]
ENPICOM Secures Funding Round To Finalize IGX Platform Development
ENPICOM SECURES FUNDING ROUND TO FINALIZE IGX PLATFORM DEVELOPMENT BOM Brabant Ventures, NextGen Ventures and [...]
Survey Results: European Immunotherapy Companies Have Great Concerns Regarding Increasing Costs And Long Development Timelines
SURVEY RESULTS: EUROPEAN IMMUNOTHERAPY COMPANIES HAVE GREAT CONCERNS REGARDING INCREASING COSTS AND LONG DEVELOPMENT TIMELINESThe Promise [...]
ENPICOM sets a new standard for B cell receptor repertoire analysis
ENPICOM SETS A NEW STANDARD FOR B CELL RECEPTOR REPERTOIRE ANALYSIS ‘s-Hertogenbosch, The Netherlands, December [...]
Towards a Predictable Combination Therapy for Multiple Cancer Types
TOWARDS A PREDICTABLE COMBINATION THERAPY FOR MULTIPLE CANCER TYPES Glycostem and [...]
New Scientific Presentation: Accelerate Your Immunotherapy Target Discovery Using Immune Repertoire Sequencing
Accelerate Your Immunotherapy Target Discovery Using Immune Repertoire Sequencing Dr. Nicola Bonzanni, Chief Scientific Officer [...]